BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21692564)

  • 1. Establishment of novel cell lines latently infected with human immunodeficiency virus 1.
    Oh YT; Kim KC; Hong KJ; Lee HS; Jang DH; Lee JS; Choi SY; Kim SS; Choi BS
    Acta Virol; 2011; 55(2):155-9. PubMed ID: 21692564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses.
    Chen BK; Saksela K; Andino R; Baltimore D
    J Virol; 1994 Feb; 68(2):654-60. PubMed ID: 7507183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel genes associated with HIV-1 latency by analysis of histone modifications.
    Kim KC; Lee S; Son J; Shin Y; Yoon CH; Kang C; Choi BS
    Hum Genomics; 2017 May; 11(1):9. PubMed ID: 28499422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells.
    Lindqvist B; Svensson Akusjärvi S; Sönnerborg A; Dimitriou M; Svensson JP
    PLoS Pathog; 2020 Jan; 16(1):e1008264. PubMed ID: 31999790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unified concept of HIV latency.
    Bagasra O
    Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
    Chun TW; Stuyver L; Mizell SB; Ehler LA; Mican JA; Baseler M; Lloyd AL; Nowak MA; Fauci AS
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13193-7. PubMed ID: 9371822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular reservoirs of HIV-1 and their role in viral persistence.
    Alexaki A; Liu Y; Wigdahl B
    Curr HIV Res; 2008 Sep; 6(5):388-400. PubMed ID: 18855649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.
    Qu X; Wang P; Ding D; Li L; Wang H; Ma L; Zhou X; Liu S; Lin S; Wang X; Zhang G; Liu S; Liu L; Wang J; Zhang F; Lu D; Zhu H
    Nucleic Acids Res; 2013 Sep; 41(16):7771-82. PubMed ID: 23804764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms of HIV-1 latency.
    Romani B; Allahbakhshi E
    Virus Genes; 2017 Jun; 53(3):329-339. PubMed ID: 28258391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.